Transcription Factor EB Is Selectively Reduced in the Nuclear Fractions of Alzheimer’s and Amyotrophic Lateral Sclerosis Brains
Neuroscience Journal · 28.06.2016 · 2016 · 1-8
DOI: 10.1155/2016/4732837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroscience Journal, erschienen am 28.06.2016. Verfasst von Hongjie Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Neurobiology, Torrey Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, FL 34987, USA. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, McLean Hospital.
Themen: Demenz
Abstract (Originalsprache)
Multiple studies suggest that autophagy is strongly dysregulated in Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS), as evidenced by accumulation of numerous autophagosomes, lysosomes with discontinuous membranes, and aggregated proteins in the patients’ brains. Transcription factor EB (TFEB) was recently discovered to be a master regulator of lysosome biogenesis and autophagy. To examine whether aberrant autophagy in AD and ALS is due to alterations in TFEB expression, we systematically quantified the levels of TFEB in these brains by immunoblotting. Interestingly, cytoplasmic fractions of AD brains showed increased levels of normalized (to tubulin) TFEB only at Braak stage IV (61%, p < 0.01 ). Most importantly, normalized (to lamin) TFEB levels in the nuclear fractions were consistently reduced starting from Braak stage IV (52%, p < 0.01 ), stage V (67%, p < 0.01 ), and stage VI (85%, p < 0.01 ) when compared to normal control (NC) brains. In the ALS brains also, nuclear TFEB levels were reduced by 62% ( p < 0.001 ). These data suggest that nuclear TFEB is selectively lost in ALS as well as AD brains, in which TFEB reduction was Braak-stage-dependent. Taken together, the observed reductions in TFEB protein levels may be responsible for the widely reported autophagy defects in these disorders.
Autor:innen und Institutionen
- Section of Neurobiology, Torrey Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, FL 34987, USA.
- Florida Institute of Technology, 150 West University Boulevard, Melbourne, FL 32901, USA.
ORCID-Profile: Ruizhi Wang, Shaohua Xu, Madepalli K Lakshmana
Förderung
- NIMH NIH HHS
- McLean Hospital
Zitieren
APA
Wang, H., Wang, R., Xu, S., & Lakshmana, M. K. (2016). Transcription Factor EB Is Selectively Reduced in the Nuclear Fractions of Alzheimer’s and Amyotrophic Lateral Sclerosis Brains. Neuroscience Journal, 2016, 1-8. https://doi.org/10.1155/2016/4732837
Vancouver
Wang H, Wang R, Xu S, Lakshmana MK. Transcription Factor EB Is Selectively Reduced in the Nuclear Fractions of Alzheimer’s and Amyotrophic Lateral Sclerosis Brains. Neuroscience Journal. 2016;2016:1-8. doi:10.1155/2016/4732837
BibTeX
@article{Wang2016,
author = {Wang, Hongjie and Wang, Ruizhi and Xu, Shaohua and Lakshmana, Madepalli K},
title = {Transcription Factor EB Is Selectively Reduced in the Nuclear Fractions of Alzheimer’s and Amyotrophic Lateral Sclerosis Brains},
journal = {Neuroscience Journal},
year = {2016},
volume = {2016},
pages = {1--8},
doi = {10.1155/2016/4732837}
}
EUVIMED